Tetraphase Pharmaceuticals Competitors, Revenue and Alternatives

Claim your profile

Overview

Location:
Boston, MA USA
Total Funding:$144.8M
Industry:Biotech
Founded:2006
Lead Investor(s):Piper Jaffray, BMO Capital Markets
Press
Claim your profile

City Ranking

Industry Ranking

State Ranking

Estimated Revenue & Financials

  • Tetraphase Pharmaceuticals's estimated annual revenue is currently $1.9M per year.
  • Tetraphase Pharmaceuticals received $6.9M in venture funding in July 2017.
  • Tetraphase Pharmaceuticals's estimated revenue per employee is $15,000
  • Tetraphase Pharmaceuticals's total funding is $144.8M.

Employee Data

  • Tetraphase Pharmaceuticals has 126 Employees.
  • Tetraphase Pharmaceuticals grew their employee count by 34% last year.
  • Tetraphase Pharmaceuticals currently has 3 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
Ohana Bioscienc...
$8.7M5660%N/A
Tango Therapeut...
$12.9M8338%N/A
Compass Therape...
$16.4M10614%N/A
Cell Signaling ...
$89.4M577N/AN/A
Momenta Pharmac...
N/A220N/AN/A
Emulate
$15.3M99-17%N/A
ArQule
N/A94N/AN/A
Hamilton Storag...
$17.2M1119%N/A
Alnylam Pharmac...
$74.9M127731%N/A
Transgenomic
N/A47N/AN/A
Missing a competitor? Contribute!?
Submit

Tetraphase Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing novel antibiotics to treat the serious and life-threatening multidrug-resistant infections that pose a major and growing global health threat. Tetraphase's proprietary breakthrough chemistry technology enables the design of molecules that can overcome antibiotic resistance. Our drug platform has led to the creation of more than 3,000 broad- and selective-spectrum antibiotic drug candidates. Tetraphase common stock trades under the NASDAQ symbol TTPH. Tetraphase is well positioned to be a major player in the multidrug-resistant arena.

keywords:N/A

126

Number of Employees

$1.9M

Revenue (est)

3

Current Jobs

34%

Employee Growth %

$144.8M

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Executive Contacts

NameTitleEmail
Patrick HornChief Marketing Officer
Guy MacdonaldCEO/President
Thomas OuelletteExecutive Director Of Marketing And Sales Training
Richard ClarkRegion Business DirectorEmail Available
Lisa SchechterRegional Account ManagerEmail Available
Maureen MontrondSenior Clinical Project Manager
Robert DeVolExecutive Director, Strategy & Market AccessEmail Available
Michael GreezSenior Manager, Commercial OperationsEmail Available
Jamie RosenvoldRegional Account ManagerEmail Available
Bruce BeardenRegional Business Director West RegionEmail Available

Tetraphase Pharmaceuticals News

12-Sep-19 - What Kind Of Shareholder Owns Most Tetraphase ...

A look at the shareholders of Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) can tell us which group is most powerful. Institutions will often ...

12-Sep-19 - Is It Time To Hold Stock? Tetraphase Pharmaceuticals (TTPH)

Tetraphase Pharmaceuticals (TTPH) is USA based company. Currently it has a market worth of $21.2M. Using market capitalization to show the ...

10-Sep-19 - Taking an Updated Look at the Data Tetraphase ...

On Monday, shares of Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) marked $0.28 per share versus a previous $0.24 closing price.

Tetraphase Pharmaceuticals Funding

DateAmountRoundLead InvestorsReference
2008-08-08$15.0MAMultipleArticle
2009-10-07$10.0MBArticle
2010-06-02$45.0MCExcel Venture ManagementArticle
2013-11-05$UndisclosedUndisclosedBMO Capital MarketsArticle
2013-11-08$45.0MUndisclosedArticle
2014-10-17$75.0MUndisclosedArticle
2014-10-24$86.3MUndisclosedArticle
2015-03-13$173.1MUndisclosedBMO Capital MarketsArticle
2017-07-28$6.9MUndisclosedPiper JaffrayArticle

Tetraphase Pharmaceuticals Executive Hires

DateNameTitleReference
2011-01-25Patrick HornChief Medical OfficerArticle
2012-01-06L Patrick GageChairmanArticle
2014-02-05Craig ThompsonCOOArticle
2015-03-06Maria StahlSVP/GENERAL COUNSELArticle
2017-10-17Kam UnninayarChief Financial OfficerArticle
2018-01-03Larry TsaiChief Medical OfficerArticle
2018-03-02Larry EdwardsCOOArticle